Variant PNPLA3 increases the HCC risk: prospective study in patients treated at the Saarland University Medical Center

M. Casper; M. Krawczyk; I. Behrmann; M. Glanemann; F. Lammert

doi:10.1055/s-0042-106308

Zeitschrift für Gastroenterologie, Table of Contents

Z Gastroenterol 2016; 54(06): 585-586
DOI: 10.1055/s-0042-106308

Leserbrief

Variant PNPLA3 increases the HCC risk: prospective study in patients treated at the Saarland University Medical Center

M. Casper

¹Department of Medicine II, Saarland University Medical Center, Homburg, Germany

,

M. Krawczyk

¹Department of Medicine II, Saarland University Medical Center, Homburg, Germany

²Laboratory of Metabolic Liver Diseases, Department of General, Transplant and Liver Surgery, Medical University of Warsaw, Warsaw, Poland

,

I. Behrmann

³Life Sciences Research Unit, University of Luxembourg, Belvaux, Luxembourg

,

M. Glanemann

⁴Department of General, Visceral, Vascular and Pediatric Surgery, University of Saarland, Homburg/Saar, Germany

,

F. Lammert

¹Department of Medicine II, Saarland University Medical Center, Homburg, Germany

› Author Affiliations

Abstract

Full Text

References

References
1 Dröge C, Häussinger D, Keitel V. Genetic variants in adult liver diseases. Z Gastroenterol 2015; 53: 1436-1446
2 Anstee QM, Seth D, Day CP. Genetic Factors That Affect Risk of Alcoholic and Non-Alcoholic Fatty Liver Disease. Gastroenterology 2016; Feb 10. pii: S0016-5085(16)00138-4. doi: 10.1053/j.gastro.2016.01.037. [Epub ahead of print]
3 Krawczyk M, Grünhage F, Zimmer V et al. Variant adiponutrin (PNPLA3) represents a common fibrosis risk gene: non-invasive elastography-based study in chronic liver disease. J Hepatol 2011; 55: 299-306
4 Yki-Jarvinen H. Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome. Lancet Diabetes Endocrinol 2014; 2: 901-910
5 Kopp J, Flessa S, Lieb W et al. Association of PNPLA3 rs738409 and TM6SF2 rs58542926 with health services utilization in a population-based study. BMC Health Serv Res 2016; 16: 41
6 Singal AG, Manjunath H, Yopp AC et al. The effect of PNPLA3 on fibrosis progression and development of hepatocellular carcinoma: a meta-analysis. Am J Gastroenterol 2014; 109: 325-334
7 Arslanow A, Stokes CS, Weber SN et al. The common PNPLA3 variant p.I148M is associated with liver fat contents as quantified by controlled attenuation parameter (CAP). Liver Int 2016; 36: 418-426
8 Liu YL, Patman GL, Leathart JB et al. Carriage of the PNPLA3 rs738409 C >G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma. J Hepatol 2014; 61: 75-81
9 Krawczyk M, Stokes CS, Romeo S et al. HCC and liver disease risks in homozygous PNPLA3p.I148M carriers approach monogenic inheritance. J Hepatol 2015; 62: 980-981